Friday, April 26, 2019

Posted at: Aug 10, 2018, 5:57 PM; last updated: Aug 10, 2018, 10:23 PM (IST)

1 student dead, 160 fall ill after taking iron tablets in Mumbai school

1 student dead, 160 fall ill after taking iron tablets in Mumbai school
Photo for representational purpose only. iStock

Shiv Kumar

Tribune News Service

Mumbai,August 10

One student died after more than 160 others taken to hospital for suspected poisoning after they consumed iron supplements provided at a school run by the Brihanmumbai Municipal Corporation.

According to the police, Chandani Mohammad Raza Sahil Shaikh (12) was among the students who were administered iron and folic acid tablets at the Municipal Urdu School Number 2 at Bainganwadi in the Mumbai suburb of Govandi. All the students were given iron and folic acid tablets as part of a programme to combat anaemia among children.

The girl's parents told police that she was ill on Tuesday, a day after consuming the tablets. She attended school afterwards but died on Thursday after vomiting blood, her parents told the police.

Following Chandani's death, parents of 161 students took them to hospital saying they had complained of nausea and vomiting over the past few days. "All the children were taken to the civic-run Rajawadi and Shatabdi Hospitals for check-ups. However there were no symptoms of any major illness," BMC said in a statement.

"The cause of the girl's death will be known only after the post-mortem on her is completed," BMC Executive Health Padmaja Keskar told reporters here.

Civic officials said 22 children were discharged from hospital while the others are undergoing treatment. None of them are serious, officials said.


All readers are invited to post comments responsibly. Any messages with foul language or inciting hatred will be deleted. Comments with all capital letters will also be deleted. Readers are encouraged to flag the comments they feel are inappropriate.
The views expressed in the Comments section are of the individuals writing the post. The Tribune does not endorse or support the views in these posts in any manner.
Share On